Truist Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $77.2M | Buy |
1,272,131
+69,974
| +6% | +$4.08M | 0.1% | 176 |
|
|
2025
Q4 | $64.8M | Sell |
1,202,157
-89,305
| -7% | -$4.3M | 0.09% | 202 |
|
|
2025
Q3 | $58.2M | Sell |
1,291,462
-27,584
| -2% | -$1.29M | 0.08% | 214 |
|
|
2025
Q2 | $61.1M | Sell |
1,319,046
-259,277
| -16% | -$12.7M | 0.09% | 208 |
|
|
2025
Q1 | $96.3M | Sell |
1,578,323
-18,827
| -1% | -$1.1M | 0.15% | 141 |
|
|
2024
Q4 | $90.3M | Buy |
1,597,150
+60,365
| +4% | +$3.37M | 0.14% | 138 |
|
|
2024
Q3 | $79.5M | Sell |
1,536,785
-14,672
| -0.9% | -$688K | 0.12% | 160 |
|
|
2024
Q2 | $64.4M | Sell |
1,551,457
-105,706
| -6% | -$4.73M | 0.1% | 194 |
|
|
2024
Q1 | $89.9M | Buy |
1,657,163
+76,960
| +5% | +$3.92M | 0.14% | 149 |
|
|
2023
Q4 | $81.1M | Sell |
1,580,203
-730,782
| -32% | -$38.4M | 0.13% | 157 |
|
|
2023
Q3 | $134M | Sell |
2,310,985
-525,196
| -19% | -$32.2M | 0.22% | 101 |
|
|
2023
Q2 | $181M | Sell |
2,836,181
-74,024
| -3% | -$4.96M | 0.3% | 77 |
|
|
2023
Q1 | $202M | Sell |
2,910,205
-88,436
| -3% | -$6.24M | 0.35% | 63 |
|
|
2022
Q4 | $216M | Sell |
2,998,641
-69,515
| -2% | -$5.24M | 0.38% | 61 |
|
|
2022
Q3 | $218M | Sell |
3,068,156
-295,021
| -9% | -$21.4M | 0.42% | 56 |
|
|
2022
Q2 | $259M | Buy |
3,363,177
+324,750
| +11% | +$24.7M | 0.48% | 48 |
|
|
2022
Q1 | $222M | Buy |
3,038,427
+35,115
| +1% | +$2.36M | 0.35% | 72 |
|
|
2021
Q4 | $187M | Sell |
3,003,312
-137,391
| -4% | -$8.06M | 0.29% | 82 |
|
|
2021
Q3 | $186M | Sell |
3,140,703
-16,669
| -0.5% | -$1.1M | 0.31% | 77 |
|
|
2021
Q2 | $211M | Sell |
3,157,372
-176,684
| -5% | -$11.5M | 0.35% | 71 |
|
|
2021
Q1 | $210M | Buy |
3,334,056
+136,613
| +4% | +$8.5M | 0.37% | 66 |
|
|
2020
Q4 | $198M | Sell |
3,197,443
-53,926
| -2% | -$3.32M | 0.38% | 61 |
|
|
2020
Q3 | $196M | Sell |
3,251,369
-388,045
| -11% | -$23.4M | 0.43% | 52 |
|
|
2020
Q2 | $214M | Buy |
3,639,414
+110,488
| +3% | +$6.61M | 0.48% | 42 |
|
|
2020
Q1 | $197M | Sell |
3,528,926
-127,043
| -3% | -$7.77M | 0.52% | 39 |
|
|
2019
Q4 | $235M | Buy |
3,655,969
+3,295,216
| +913% | +$189M | 0.48% | 45 |
|
|
2019
Q3 | $18.3M | Buy |
360,753
+9,974
| +3% | +$469K | 0.31% | 84 |
|
|
2019
Q2 | $15.9M | Buy |
350,779
+10,576
| +3% | +$493K | 0.28% | 95 |
|
|
2019
Q1 | $16.2M | Buy |
340,203
+10,956
| +3% | +$546K | 0.29% | 90 |
|
|
2018
Q4 | $17.1M | Buy |
329,247
+55,374
| +20% | +$2.98M | 0.35% | 72 |
|
|
2018
Q3 | $17M | Buy |
273,873
+9,659
| +4% | +$573K | 0.31% | 85 |
|
|
2018
Q2 | $14.6M | Buy |
264,214
+5,832
| +2% | +$315K | 0.28% | 94 |
|
|
2018
Q1 | $16.3M | Sell |
258,382
-7,094
| -3% | -$456K | 0.31% | 88 |
|
|
2017
Q4 | $16.3M | Sell |
265,476
-3,559
| -1% | -$223K | 0.3% | 85 |
|
|
2017
Q3 | $17.1M | Sell |
269,035
-3,368
| -1% | -$197K | 0.33% | 79 |
|
|
2017
Q2 | $15.2M | Sell |
272,403
-43,144
| -14% | -$2.35M | 0.3% | 91 |
|
|
2017
Q1 | $17.2M | Buy |
315,547
+50,873
| +19% | +$2.79M | 0.34% | 77 |
|
|
2016
Q4 | $15.5M | Sell |
264,674
-41,838
| -14% | -$2.29M | 0.32% | 82 |
|
|
2016
Q3 | $16.5M | Buy |
306,512
+42,172
| +16% | +$2.71M | 0.34% | 84 |
|
|
2016
Q2 | $19.4M | Buy |
264,340
+55,048
| +26% | +$3.89M | 0.41% | 65 |
|
|
2016
Q1 | $13.4M | Sell |
209,292
-32,590
| -13% | -$2.06M | 0.35% | 75 |
|
|
2015
Q4 | $16.6M | Sell |
241,882
-10,875
| -4% | -$719K | 0.43% | 57 |
|
|
2015
Q3 | $15M | Buy |
252,757
+4,833
| +2% | +$307K | 0.39% | 66 |
|
|
2015
Q2 | $16.5M | Buy |
247,924
+22,328
| +10% | +$1.47M | 0.45% | 60 |
|
|
2015
Q1 | $14.6M | Sell |
225,596
-22,312
| -9% | -$1.4M | 0.42% | 69 |
|
|
2014
Q4 | $14.6M | Sell |
247,908
-7,836
| -3% | -$442K | 0.43% | 66 |
|
|
2014
Q3 | $13.1M | Sell |
255,744
-7,008
| -3% | -$350K | 0.4% | 73 |
|
|
2014
Q2 | $12.7M | Buy |
262,752
+18,204
| +7% | +$897K | 0.38% | 76 |
|
|
2014
Q1 | $12.7M | Buy |
244,548
+13,212
| +6% | +$703K | 0.4% | 69 |
|
|
2013
Q4 | $12.3M | Buy |
231,336
+7,741
| +3% | +$394K | 0.4% | 69 |
|
|
2013
Q3 | $10.3M | Sell |
223,595
-28,146
| -11% | -$1.24M | 0.37% | 73 |
|
|
2013
Q2 | $11.3M | Buy |
+251,741
| New | +$10.9M | 0.42% | 61 |
|
Other funds holding BMY
VCM
VPM
Truist Financial's BMY Position: Q1 2026 in Review
Truist Financial increased its Bristol-Myers Squibb (BMY) stake by 5.8% in Q1 2026, buying an estimated $4.08M and bringing the position to 1,272,131 shares worth $77.2M. The position accounts for 0.1% of the portfolio, ranked #176.
Truist Financial first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $259M in Q2 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Truist Financial held 1,272,131 shares of Bristol-Myers Squibb worth $77.2M as of Q1 2026.
- Truist Financial bought 69,974 Bristol-Myers Squibb shares in Q1 2026, an estimated $4.08M.
- Bristol-Myers Squibb made up 0.1% of Truist Financial's portfolio in Q1 2026, its #176 holding.
- Truist Financial first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Truist Financial's Bristol-Myers Squibb position peaked at $259M in Q2 2022.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.